These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
6901 results:

  • 1. Genomic Alterations and Clinical Characterization in Chinese Patients with Metastatic colorectal cancer.
    Zhang XH; Zhou JQ; Wei Q; Li J; Xu T; Bai CM; Zhou JF; Wang XC
    Discov Med; 2024 Jul; 36(186):1477-1485. PubMed ID: 39054718
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long noncoding RNA LINC01550 inhibits colorectal cancer malignancy by suppressing the Wnt/β-catenin signaling pathway.
    Wu W; Li A; He H; Ye S; Zhou Z; Quan JH; Tan W
    J Biochem Mol Toxicol; 2024 Aug; 38(8):e23774. PubMed ID: 39041324
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. LncRNA CARMN m6A demethylation by ALKBH5 inhibits mutant p53-driven tumour progression through miR-5683/FGF2.
    Liu N; Jiang X; Zhang G; Long S; Li J; Jiang M; Jia G; Sun R; Zhang L; Zhang Y
    Clin Transl Med; 2024 Jul; 14(7):e1777. PubMed ID: 39039912
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
    Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
    [No Abstract]    [Full Text] [Related]  

  • 5. Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance.
    Heczko L; Liška V; Vyčítal O; Fiala O; Šůsová S; Hlaváč V; Souček P
    Hum Genomics; 2024 Jul; 18(1):83. PubMed ID: 39030589
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic implications of immunohistochemistry in patients with endometrial cancer.
    Anca-Stanciu MB; Manu A; Olinca MV; Coroleucă BC; Comandaşu DE; Coroleucă CA; Maier C; Brătilă E
    Rom J Morphol Embryol; 2024; 65(2):185-193. PubMed ID: 39020532
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Dasabuvir alleviates 5-fluorouracil-induced intestinal injury through anti-senescence and anti-inflammatory.
    He S; Wang Z; Xia J; Jia H; Dai Q; Chen C; He F; Wang X; Zhou M
    Sci Rep; 2024 Jul; 14(1):15730. PubMed ID: 38977864
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Detection of PIK3CA gene mutation and its related prognosis in colorectal cancer based on next-generation sequencing].
    Peng X; Zhang X; Lu HX; Shen LL; Gao N; Zan LK
    Zhonghua Bing Li Xue Za Zhi; 2024 Jul; 53(7):716-721. PubMed ID: 38955704
    [No Abstract]    [Full Text] [Related]  

  • 9. Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of KRAS or BRAF mutational status.
    Zhang J; Zhou L; Zhao S; El-Deiry WS
    Oncotarget; 2024 Jul; 15():424-438. PubMed ID: 38953895
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Bioinformatic Identification of tp53 Gene Mutation Hotspots in colorectal cancer.
    Kovács Z; Sugimura H; György TA; Osvath E; Manirakiza F; Gurzu S
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928318
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Anthraquinone Derivative C2 Enhances Oxaliplatin-Induced Cell Death and Triggers Autophagy via the PI3K/AKT/mTOR Pathway.
    Li Y; Yan W; Qin Y; Zhang L; Xiao S
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928176
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Working title: Molecular involvement of p53-MDM2 interactome in gastrointestinal cancers.
    Yedla P; Bhamidipati P; Syed R; Amanchy R
    Cell Biochem Funct; 2024 Jun; 42(4):e4075. PubMed ID: 38924101
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. USP11 modulates mitotic progression and senescence by regulating the p53-p21 axis through MDM2 deubiquitination.
    Kim WJ; Basit A; Lee JH
    Biochem Biophys Res Commun; 2024 Sep; 726():150275. PubMed ID: 38901057
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer.
    Chen SH; Tse KP; Lu YJ; Chen SJ; Tian YF; Tan KT; Li CF
    Cancer Med; 2024 Jun; 13(12):e7384. PubMed ID: 38895905
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of Oncogenic Changes in p53 and KRAS on Macropinocytosis and Ferroptosis in Colon cancer Cells and Anticancer Efficacy of Niclosamide with Differential Effects on These Two Processes.
    Nguyen NT; Sennoune SR; Dharmalingam-Nandagopal G; Sivaprakasam S; Bhutia YD; Ganapathy V
    Cells; 2024 May; 13(11):. PubMed ID: 38891084
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. APR-246 as a radiosensitization strategy for mutant p53 cancers treated with alpha-particles-based radiotherapy.
    Michaeli O; Luz I; Vatarescu M; Manko T; Weizman N; Korotinsky Y; Tsitrina A; Braiman A; Arazi L; Cooks T
    Cell Death Dis; 2024 Jun; 15(6):426. PubMed ID: 38890278
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Integrative network analysis of transcriptomics data reveals potential prognostic biomarkers for colorectal cancer.
    Mahajan M; Sarkar A; Mondal S
    Cancer Med; 2024 Jun; 13(11):e7391. PubMed ID: 38872418
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cytotoxicity of alkaloids isolated from Peganum harmala seeds on HCT116 human colon cancer cells.
    Salimizadeh Z; Enferadi ST; Majidizadeh T; Mahjoubi F
    Mol Biol Rep; 2024 Jun; 51(1):732. PubMed ID: 38872006
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Unlocking the potential of flavonoids: Natural solutions in the fight against colon cancer.
    Hasibuan PAZ; Simanjuntak Y; Hey-Hawkins E; Lubis MF; Rohani AS; Park MN; Kim B; Syahputra RA
    Biomed Pharmacother; 2024 Jul; 176():116827. PubMed ID: 38850646
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Advanced Design, Synthesis, and Evaluation of Highly Selective Wee1 Inhibitors: Enhancing Pharmacokinetics and Antitumor Efficacy.
    Wang Y; Xu C; Jiang Y; Tu Z; Yan J; Guo L; Dong C; Liu J; Yang X; Wang Z; Lu T; Feng J; Chen Y
    J Med Chem; 2024 Jun; 67(12):9927-9949. PubMed ID: 38847373
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 346.